SCHEMBL2483046

SCHEMBL2483046

CC(NCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASR P41180 7/20 0.74
ADRA2C P18825 3/20 0.74
SLC6A4 P31645 3/20 0.74
DRD3 P35462 3/20 0.74
HTR2C P28335 3/20 0.74
SLC6A2 P23975 2/20 0.74
OPRM1 P35372 2/20 0.74
MLNR O43193 1/20 0.74
ABCB11 O95342 1/20 0.74
ADRB1 P08588 1/20 0.74
ADORA3 P0DMS8 1/20 0.74
CYP2D6 P10635 1/20 0.74
CHRM1 P11229 1/20 0.74
DRD2 P14416 1/20 0.74
CHRM3 P20309 1/20 0.74
GLRA1 P23415 1/20 0.74
AVPR2 P30518 1/20 0.74
HRH1 P35367 1/20 0.74
MC3R P41968 1/20 0.74
HTT P42858 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2502962 1.00 CASR (0.74) CASRADRA2CSLC6A4DRD3HTR2C
SCHEMBL12495443 1.00 CASR (0.74) CASRADRA2CSLC6A4DRD3HTR2C
SCHEMBL13077949 0.89 CASR (0.60) CASRADRA2CSLC6A4DRD3HTR2C
SCHEMBL17915496 0.88 CASR (0.87) CASRADRA2CSLC6A4DRD3HTR2C
SCHEMBL17053439 0.88 CASR (0.87) CASRADRA2CSLC6A4DRD3HTR2C
SCHEMBL13077646 0.87 CASR (0.60) CASRADRA2CSLC6A4DRD3HTR2C
SCHEMBL13077594 0.86 CASR (0.57) CASRADRA2CSLC6A4DRD3HTR2C
Cinacalcet SCHEMBL3227084 0.85 CASR (1.00) CASRADRA2CSLC6A4DRD3HTR2C
Cinacalcet SCHEMBL71876 0.85 CASR (1.00) CASRADRA2CSLC6A4DRD3HTR2C
Cinacalcet SCHEMBL30371982 0.85 CASR (1.00) CASRADRA2CSLC6A4DRD3HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376424-A1 HIGHLY PURE CINACALCET OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Actavis Group PTC EHF (IS) 2011-10-19 EP disclosed
WO-2010067204-A1 HIGHLY PURE CINACALCET OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF ACTAVIS GROUP PTC EHF (IS) 2010-06-17 WO disclosed
WO-2010067204-A1 HIGHLY PURE CINACALCET OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF ACTAVIS GROUP PTC EHF (IS) 2010-06-17 WO disclosed